1.30

1.56% 0.02

Heron Therapeutics Inc (HRTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HRTX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.28

Aprire:

$1.29

Volume 24 ore:

525.30K

Relative Volume:

0.31

Capitalizzazione di mercato:

$239.23M

Reddito:

$137.74M

Utile/perdita netta:

$-27.97M

Rapporto P/E:

-8.125

EPS:

-0.16

Flusso di cassa netto:

$-9.61M

1 W Prestazione:

-2.99%

1M Prestazione:

+3.17%

6M Prestazione:

-31.94%

1 anno Prestazione:

-29.35%

Intervallo 1D:

$1.285

$1.33

Intervallo di 1 settimana:

$1.275

$1.385

Portata 52W:

$1.04

$2.68

Heron Therapeutics Inc Stock (HRTX) Company Profile

Nome

Heron Therapeutics Inc

Settore

Healthcare (1146)

Industria

Biotechnology (637)

Telefono

(858) 251-4400

Indirizzo

4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA

Dipendente

122

Cinguettio

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

HRTX's Discussions on Twitter

Confronta HRTX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HRTX Heron Therapeutics Inc	1.305	234.64M	137.74M	-27.97M	-9.61M	-0.16
VRTX Vertex Pharmaceuticals Inc	408.36	104.55B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	472.58	60.36B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	562.13	59.84B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	803.82	49.07B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	330.05	35.16B	4.56B	-176.77M	225.30M	-1.7177

Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-06-09	Iniziato	H.C. Wainwright	Buy
2024-06-13	Iniziato	Rodman & Renshaw	Buy
2024-04-23	Iniziato	CapitalOne	Overweight
2024-03-13	Reiterato	Needham	Buy
2020-05-27	Iniziato	Guggenheim	Buy
2020-02-20	Reiterato	Needham	Buy
2019-01-16	Reiterato	Needham	Buy
2018-04-05	Iniziato	Evercore ISI	Outperform
2018-03-19	Reiterato	Mizuho	Buy
2018-03-01	Reiterato	Needham	Buy
2018-01-03	Iniziato	Leerink Partners	Outperform
2017-09-27	Iniziato	Northland Capital	Outperform
2017-02-27	Iniziato	Needham	Buy
2016-10-26	Iniziato	Aegis Capital	Buy
2016-09-06	Ripresa	Lake Street	Buy
2016-05-03	Iniziato	Cantor Fitzgerald	Buy
2015-12-10	Iniziato	Lake Street	Buy
2015-09-23	Reiterato	Leerink Partners	Outperform
2015-09-02	Iniziato	BofA/Merrill	Buy
2015-08-03	Reiterato	Brean Capital	Buy
2015-06-30	Reiterato	JMP Securities	Mkt Outperform
2015-06-19	Reiterato	Leerink Partners	Outperform
2014-08-07	Iniziato	Noble Financial	Buy

Mostra tutto

Heron Therapeutics Inc Borsa (HRTX) Ultime notizie

10:52 AM

Building trade automation scripts for Heron Therapeutics Inc.2025 Technical Overview & Verified Trade Idea Suggestions - newser.com

10:52 AM

10:46 AM

Published on: 2025-10-13 09:46:10 - newser.com

10:46 AM

09:21 AM

Why Heron Therapeutics Inc. stock could benefit from AI revolutionQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - newser.com

09:21 AM

09:05 AM

Can Heron Therapeutics Inc. stock weather global recessionMarket Risk Report & Free Low Drawdown Momentum Trade Ideas - newser.com

09:05 AM

01:41 AM

Heron Therapeutics Inc. stock prediction for this weekQuarterly Performance Summary & Technical Buy Zone Confirmation - newser.com

01:41 AM

Oct 12, 2025

Cyndeo Wealth Partners LLC Takes Position in Heron Therapeutics, Inc. $HRTX - MarketBeat

Oct 12, 2025

Is Heron Therapeutics Inc AXD2 a good long term investment - earlytimes.in

Oct 12, 2025

Oct 11, 2025

Heron Therapeutics (NASDAQ:HRTX) Upgraded at Zacks Research - Defense World

Oct 11, 2025

Oct 10, 2025

Heron Therapeutics (NASDAQ:HRTX) Stock Rating Upgraded by Zacks Research - MarketBeat

Oct 10, 2025

Chart based analysis of Heron Therapeutics Inc. trendsBear Alert & Momentum Based Trading Signals - newser.com

Oct 10, 2025

Oct 09, 2025

How Heron Therapeutics Inc. (AXD2) stock reacts to stronger dollarMarket Sentiment Report & Real-Time Buy Signal Notifications - newser.com

Oct 09, 2025

Heron Therapeutics (NASDAQ:HRTX) Earns "Sell (E+)" Rating from Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 06, 2025

Why Heron Therapeutics Inc. is moving today2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Heron Therapeutics Inc. stock retracement – recovery analysisTrade Exit Summary & Entry Point Confirmation Alerts - newser.com

Oct 05, 2025

Is Heron Therapeutics Inc. stock positioned well for digital economyShort Setup & Smart Money Movement Alerts - newser.com

Oct 05, 2025

Why Heron Therapeutics Inc. stock remains on buy lists2025 AllTime Highs & Verified Short-Term Plans - newser.com

Oct 05, 2025

What data driven models say about Heron Therapeutics Inc.’s future - newser.com

Oct 05, 2025

Oct 03, 2025

Why Heron Therapeutics Inc. (AXD2) stock could be top winnerChart Signals & Smart Money Movement Tracker - newser.com

Oct 03, 2025

Oct 01, 2025

Published on: 2025-10-01 09:34:43 - newser.com

Oct 01, 2025

Chart overlay techniques for tracking Heron Therapeutics Inc.Trade Analysis Summary & Reliable Price Breakout Alerts - newser.com

Oct 01, 2025

Sep 29, 2025

Why Heron Therapeutics Inc. (AXD2) stock signals breakout potentialJuly 2025 Earnings & Consistent Growth Equity Picks - newser.com

Sep 29, 2025

Sep 28, 2025

What analysts say about Heron Therapeutics Inc AXD2 stockFundamental Strength Indicators & Free Hedging Tactics for Volatile Markets - Early Times

Sep 28, 2025

Sep 27, 2025

Is Heron Therapeutics Inc a good long term investmentSector Rotation Strategies & Free Dynamic Capital Growth - Early Times

Sep 27, 2025

Sep 24, 2025

Heron Therapeutics Strengthens Financial Position with Refinancing - MSN

Sep 24, 2025